Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models

被引:30
|
作者
Mikell, Justin K. [1 ,5 ]
Mahvash, Armeen [2 ]
Siman, Wendy [1 ,5 ]
Baladandayuthapani, Veera [3 ,5 ]
Mourtada, Firas [4 ,6 ,7 ]
Kappadath, S. Cheenu [1 ,5 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA
[5] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA
[6] Christiana Care, Dept Radiat Oncol, Newark, DE USA
[7] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA
基金
美国国家卫生研究院;
关键词
HEPATOCELLULAR-CARCINOMA PATIENTS; TREATMENT PLANNING STRATEGY; METASTATIC LIVER-CANCER; TC-99M MAA; RADIOEMBOLIZATION; SPECT; HEPATOCARCINOMA; PREDICTS; SURVIVAL; EFFICACY;
D O I
10.1016/j.ijrobp.2016.07.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To quantify differences that exist between dosimetry models used for Y-90 selective internal radiation therapy (SIRT). Methods and Materials: Retrospectively, 37 tumors were delineated on 19 post- therapy quantitative Y-90 single photon emission computed tomography/computed tomography scans. Using matched volumes of interest (VOIs), absorbed doses were reported using 3 dosimetry models: glass microsphere package insert standard model (SM), partition model (PM), and Monte Carlo (MC). Univariate linear regressions were performed to predict mean MC from SM and PM. Analysis was performed for 2 subsets: cases with a single tumor delineated (best case for PM), and cases with multiple tumors delineated (typical clinical scenario). Variability in PM from the ad hoc placement of a single spherical VOI to estimate the entire normal liver activity concentration for tumor (T) to nontumoral liver (NL) ratios (TNR) was investigated. We interpreted the slope of the resulting regression as bias and the 95% prediction interval (95% PI) as uncertainty. MCNLsingle represents MC absorbed doses to the NL for the single tumor patient subset; other combinations of calculations follow a similar naming convention. Results: SM was unable to predict MCTsingle or MCTmultiple (p>.12, 95% PI > +/- 177 Gy). However, SMsingle was able to predict (p<.012) MCNLsingle , albeit with large uncertainties; SMsingle and SMmultiple yielded biases of 0.62 and 0.71, and 95% PI of +/- 40 and +/- 32 Gy, respectively. PMTsingle and PMTmultiple predicted (p< 2E-6) MC(T)(single)and MCTmultiple with biases of 0.52 and 0.54, and 95% PI of +/- 38 and +/- 111 Gy, respectively. The TNR variability in PMTsingle increased the 95% PI for predicting MCTsingle (bias = 0.46 and 95% PI = +/- 103 Gy). The TNR variability in PMTmultiple modified the bias when predicting MCTmultiple (bias = 0.32 and 95% PI = +/- 110 Gy). Conclusions: The SM is unable to predict mean MC tumor absorbed dose. The PM is statistically correlated with mean MC, but the resulting uncertainties in predicted MC are large. Large differences observed between dosimetry models for Y-90 SIRT warrant caution when interpreting published SIRT absorbed doses. To reduce uncertainty, we suggest the entire NLVOI be used for TNR estimates when using PM. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:888 / 896
页数:9
相关论文
共 50 条
  • [21] Imaging for Selective Internal Radiation Therapy (SIRT) with Intraarterial Infusion of Yttrium-90 (Y-90) Microspheres: Pearls and Pitfalls
    Ersahin, Devrim
    Chen, Ming-Kai
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [22] Yttrium-90 Microsphere Selective Internal Radiation Therapy-Induced Cholecystitis
    Pantaleon Vasquez, Robert
    Karamchandani, Dipti M.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2020, 28 (06) : 649 - 650
  • [23] Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined with Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma: The SIROCHO Trial Design
    Edeline, Julien
    Rolland, Yan
    Campillo-Gimenez, Boris
    Bourien, Heloise
    Trochet, Marion
    Garin, Etienne
    Boudjema, Karim
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 21 - 22
  • [24] Clinical and Laboratory Toxicity After Selective Internal Radiation Therapy (SIRT) Using Yttrium-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma
    Gabrielson, A.
    Banovac, F.
    Kim, A.
    Unger, K. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E151 - E151
  • [25] Evaluation of Lung Dose Using Voxel-based Dosimetry with SPECT/CT for Yttrium-90 Selective Internal Radiation Therapy of Liver Cancer
    Potrebko, P.
    Andl, G.
    Bose, S.
    Fox, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E725 - E725
  • [26] Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined with Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma: The SIROCHO Trial Design
    Julien Edeline
    Yan Rolland
    Boris Campillo-Gimenez
    Héloïse Bourien
    Marion Trochet
    Etienne Garin
    Karim Boudjema
    Annals of Surgical Oncology, 2023, 30 : 21 - 22
  • [27] Key role of personalized dosimetry in dose adjustement for selective internal radiotherapy : retrospective study of patients treated with yttrium-90 resin microspheres
    Subreville, C.
    Pinaquy, J.
    Miguel, J.
    Buj, S.
    Bordenave, L.
    Debordeaux, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S234 - S235
  • [28] Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study
    Mantry, Parvez S.
    Mehta, Ashwini
    Madani, Bahar
    Mejia, Alejandro
    Shahin, Islam
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (05) : 799 - +
  • [29] Local experience in Saudi Arabia of selective internal radiation therapy with yttrium-90 microspheres for the treatment of unresectable liver tumours
    Al Omran, Bedoor
    Hamour, Nazar
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2019, 18 (04) : 365 - 368
  • [30] Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus
    Kennedy, Andrew
    Brown, Daniel B.
    Feilchenfeldt, Jonas
    Marshall, John
    Wasan, Harpreet
    Fakih, Marwan
    Gibbs, Peter
    Knuth, Alexander
    Sangro, Bruno
    Soulen, Michael C.
    Pittari, Gianfranco
    Sharma, Ricky A.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (06) : 1079 - 1099